Genetics and novel aspects of therapies in systemic lupus erythematosusAUTOIMMUNITY REVIEWSIF8.32015-11-0155PREAI
Mast Cell deficient KitW-sh Sash Mutant Mice Display Aberrant Myelopoiesis Leading to the Accumulation of Splenocytes That Act as Myeloid-Derived Suppressor CellsJOURNAL OF IMMUNOLOGYIF3.42013-06-0135OAAI
Intronic Promoters and Their Noncoding Transcripts: A New Source of Cancer-Associated GenesMOLECULAR CARCINOGENESISIF3.22012-08-285PREAI
PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener's granulomatosisRHEUMATOLOGY INTERNATIONALIF2.92012-04-068PREAI
THE DISCOVERY OF TESTICULAR PODOCIN REVEALS A NEW APPROACH FOR THE PATHOPHYSIOLOGY OF SERTOLI CELL ONLY SYNDROMEJOURNAL OF UROLOGYIF6.82011-04-010PREAI
Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in miceKIDNEY INTERNATIONALIF12.62011-02-0147OAAI
Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus ErythematosusJOURNAL OF RHEUMATOLOGYIF3.42009-12-01144OAAI
Downregulation of α-galactosidase A upregulates CD77: functional impact for Fabry nephropathyKIDNEY INTERNATIONALIF12.62009-02-0126OAAI
Interferon-β:: A therapeutic for autoimmune lupus in MRL-Faslpr miceJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYIF9.42005-11-0160OAAI